Skip to main content
. 2010 Summer;15(2):e20–e24.

Figure 2).

Figure 2)

Comparison of 30-day mortality outcome in patients treated with glucose-insulin-potassium (GIK) therapy. ORs and 95% CIs are presented for individual studies and pooled data. ECLA Estudios Cardiologicos Latinoamerica; GIPS Glucose-Insulin-Potassium Study; MRC Medical Research Council; OASIS Organization for the Assessment of Strategies for Ischemic Syndromes trial; Pol-GIK Polish GIK trial